Cardiovascular Conditions

Question 1

Classifications of cholesterol types, and levels with TG

Answer 1

417

Question 2

Classification of dyslipidemia

Answer 2

418

Question 3

Calculating ASCVD risk

Answer 3

418

Question 4

Select drugs and conditions that raise LDL or TG levels

Answer 4

418

Question 5

Non-drug treatment of dyslipidemia

Answer 5

419

Question 6

Natural products to treat dyslipidemia

Answer 6

419

Question 7

Statin treatment intensity definitions and selection options

Answer 7

419/420

Question 8

Equivalent doses of statins

Answer 8

420

Question 9

Managing myalgias from statins

Answer 9

420

Question 10

Statin drug names and doses

Answer 10

421

Question 11

Statin safety, side effects, and monitoring

Answer 11

421

Question 12

Statin drug interactions

Answer 12

421

Question 13

Determining need for add-on treatments

Answer 13

422

Question 14

Ezetimibe (Zetia)

Answer 14

422

Question 15

Proprotein convertase subtilisin/kexin type 9 monoclonal antibodies (PCSK9)

Answer 15

423

Question 16

Bile acid sequestrants or binding resins

Answer 16

423

Question 17

Fibrates

Answer 17

424

Question 18

Niacin

Answer 18

425

Question 19

Fish oils

Answer 19

426

Question 20

Other dyslipidemia drug treatments

Answer 20

426

Question 21

Key counseling points for dyslipidemia

Answer 21

427

Question 22

Pathophysiology of hypertension

Answer 22

428/429

Question 23

Screening and diagnosis of hypertension

Answer 23

430

Question 24

Key drugs that increase blood pressure

Answer 24

430

Question 25

Lifestyle management in hypertension

Answer 25

430

Question 26

Natural products for hypertension

Answer 26

431

Question 27

Guideline recommendations on treatment

Answer 27

431

Question 28

Hypertension in pregnancy

Answer 28

431

Question 29

Combination drug names

Answer 29

432

Question 30

Thiazide-type diuretics

Answer 30

432/433

Question 31

Calcium channel blockers: dihydropyridine

Answer 31

434

Question 32

Calcium channel blockers: non dihydropyridine

Answer 32

435

Question 33

Angiotensin-converting enzyme inhibitors (ACE)

Answer 33

436

Question 34

Angiotensin receptor blockers (ARB)

Answer 34

437

Question 35

Direct renin inhibitor

Answer 35

437

Question 36

Potassium-sparing diuretics

Answer 36

438

Question 37

Beta-blockers: B-1 selective

Answer 37

439

Question 38

Beta-blockers: B-1 selective with nitric oxide-dep vasodilation

Answer 38

439

Question 39

Beta-blockers: Beta nonselective

Answer 39

440

Question 40

Beta-blockers: Beta and alpha-1 nonselective

Answer 40

440

Question 41

Centrally acting alpha-2 adrenergic agonists

Answer 41

441

Question 42

Direct vasodilators

Answer 42

441

Question 43

Hypertensive urgency and emergency

Answer 43

442

Question 44

Key counseling points for hypertension

Answer 44

442

Question 45

Evaluation of stable ischemic HD

Answer 45

444

Question 46

Non-drug treatment for SIHD

Answer 46

444

Question 47

Treatment approach for SIHD

Answer 47

444

Question 48

Antiplatelet drugs: aspirin

Answer 48

445

Question 49

Antiplatelet drugs: clopidogrel (Plavix)

Answer 49

445

Question 50

Dual antiplatelet therapy (DAPT)

Answer 50

445

Question 51

Antianginal treatments

Answer 51

446

Question 52

Nitroglycerin in SIHD

Answer 52

447

Question 53

Key counseling points in SIHD

Answer 53

448

Question 54

Risk factors in acute coronary syndrome

Answer 54

449

Question 55

Diagnosis, signs, and symptoms of ACS

Answer 55

449/450

Question 56

Comparing UA, NSTEMI, and STEMI

Answer 56

450

Question 57

PCI or medical management

Answer 57

450

Question 58

Drug treatment options for ACS

Answer 58

450

Question 59

Order of operations for drugs in ACS

Answer 59

451

Question 60

Medications to avoid in the acute setting of ACS

Answer 60

451

Question 61

Antiplatelet drugs used in ACS

Answer 61

452/453

Question 62

Glycoprotein IIb/IIIa receptor antagonists

Answer 62

454

Question 63

Protease-activated receptor-1 antagonists

Answer 63

454

Question 64

Fibrinolytic

Answer 64

455

Question 65

Secondary prevention of ACS

Answer 65

456

Question 66

Diagnosis of HF through ejection fraction

Answer 66

458

Question 67

Classification of HF

Answer 67

458

Question 68

Signs and symptoms of HF

Answer 68

458

Question 69

Pathophysiology of HF

Answer 69

459

Question 70

Lifestyle management of HF

Answer 70

459

Question 71

Key drugs that cause or worsen HF

Answer 71

459

Question 72

Types of HF

Answer 72

461

Question 73

Initial treatment of HFrEF

Answer 73

460

Question 74

Neprilysin inhibitor

Answer 74

461

Question 75

Guideline-directed ACEI/ARBs

Answer 75

462

Question 76

Guideline-directed beta-blockers

Answer 76

463

Question 77

Aldosteron receptor antagonists

Answer 77

464

Question 78

Sodium-glucose cotransporter 2 inhibitors (SGLT2I)

Answer 78

Diabetes chapter

Question 79

Loop diuretics

Answer 79

465

Question 80

Hydralazine with nitrate

Answer 80

466

Question 81

Ivabradine

Answer 81

467

Question 82

Digoxin

Answer 82

467/468

Question 83

Vericiguat

Answer 83

468

Question 84

Potassium pills

Answer 84

469

Question 85

Action plan for HF

Answer 85

470

Question 86

Key counseling points for HF

Answer 86

471

Question 87

Normal cardiac conduction pathway

Answer 87

473

Question 88

Normal cardiac action potential

Answer 88

474

Question 89

Types of arrhythmias

Answer 89

474/475

Question 90

Key drugs that prolong the QT interval

Answer 90

475

Question 91

Classification of antiarrhythmic drugs

Answer 91

476

Question 92

Types of AF

Answer 92

476

Question 93

Rate control of AF

Answer 93

477

Question 94

Rhythm control of AF

Answer 94

477

Question 95

Stroke prophylaxis in AF

Answer 95

477

Question 96

Amiodarone

Answer 96

478

Question 97

Digoxin

Answer 97

479

Question 98

Non-DHP CCB in AF

Answer 98

479

Question 99

Class Ia antiarrhythmics

Answer 99

480/481

Question 100

Class Ib antiarrhythmics

Answer 100

481

Question 101

Class Ic antiarrhythmics

Answer 101

481

Question 102

Class III antiarrhythmics

Answer 102

482

Question 103

Adenosine

Answer 103

483

Question 104

Key counseling points for arrhythmias

Answer 104

483

Question 105

Types of strokes

Answer 105

484

Question 106

Risk factors for stroke

Answer 106

485

Question 107

Signs and symptoms of stroke

Answer 107

485

Question 108

Alteplase

Answer 108

486

Question 109

Bleeding risk with alteplase

Answer 109

485

Question 110

Treatment of stroke

Answer 110

486

Question 111

Secondary prevention of stroke

Answer 111

487/488

Question 112

Types of hemorrhagic stroke

Answer 112

489

Question 113

Treatment of ICH

Answer 113

489

Question 114

Treatment of SAH

Answer 114

490